Atoltivimab, Maftivimab, And Odesivimab
Generic Name: atoltivimab, maftivimab, and odesivimab
Dosage form: INJECTION, SOLUTION. Active ingredients: ATOLTIVIMAB-EBGN (483.3 mg/14.5mL); MAFTIVIMAB-EBGN (483.3 mg/14.5mL); ODESIVIMAB-EBGN (483.3 mg/14.5mL). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: INJECTION, SOLUTION. Active ingredients: ATOLTIVIMAB-EBGN (483.3 mg/14.5mL); MAFTIVIMAB-EBGN (483.3 mg/14.5mL); ODESIVIMAB-EBGN (483.3 mg/14.5mL). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as injection, solution.
Related Medications
Sodium Chloride, Sodium Gluconate, Sodium Acetate, Potassium Chloride, Magnesium Chloride, Sodium Phosphate, Dibasic, And Potassium Phosphate
sodium chloride, sodium gluconate, sodium acetate, potassium chloride, magnesium chloride, sodium phosphate, dibasic, and potassium phosphate
DESCRIPTION Each 100 mL of Isolyte ® S pH 7.4 (Multi-Electrolyte Injection) contains: Sodium Chloride USP 0.53 g; Sodium Gluconate USP 0.5 g Sodium Acetate Trihydrate USP 0.37 g; Potassium Chloride USP 0.037 g Magnesium Chloride Hexahydrate USP 0.03 g Dibasic Sodium Phosphate Heptahydrate USP 0.012 g Monobasic Potassium Phosphate NF 0.00082 g; Water for Injection USP qs pH may be adjusted with Glacial Acetic Acid USP or Sodium Hydroxide NF pH: 7.4 (7.0–7.8) Calculated Osmolarity: 295 mOsmol/lite
Glatiramer Acetate
glatiramer acetate
11 DESCRIPTION Glatiramer acetate, the active ingredient of glatiramer acetate injection, consists of the acetate salts of synthetic polypeptides, containing four naturally occurring amino acids: L-glutamic acid, L-alanine, L-tyrosine, and L-lysine with an average molar fraction of 0.141, 0.427, 0.095, and 0.338, respectively. The average molecular weight of glatiramer acetate is 5,000 – 9,000 daltons. Glatiramer acetate is identified by specific antibodies.
Lebrikizumab
lebrikizumab
Dosage form: LIQUID. Active ingredients: LEBRIKIZUMAB (5 kg/5kg). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.